CLIA lab proteomics that analyzes proteins from tumor tissue to identify biomarkers that may inform treatment.
Consented intake · your records travel with you · nothing moves without your sign-off
mProbe runs proteomics in a CLIA lab, mapping and analyzing proteins using FFPE tumor tissue as input. The analysis models the signature pathways of cancer cells to identify biomarkers and inform treatment. For patients, the CLIA lab setting means results come from a clinically certified environment rather than a research-only pipeline.
Prefer the source? mProbe (CLIA lab, FFPE input)'s own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how mProbe (CLIA lab, FFPE input) handles billing.
We don't have confirmed insurance details for mProbe (CLIA lab, FFPE input) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in mProbe's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.